spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  NexMed 

 HSMN NewsFeed - 18 Jan 2017
Apricus Biosciences Announces Approval of Vitaros(R) for the Treatment of Erectile Dysfunction in Mexico
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Dec 2016
Apricus Biosciences Announces the Launch of Vitaros(R) for the Treatment of Erectile Dysfunction in Lebanon by Elis Pharmaceuticals
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 18 Nov 2016
Apricus Biosciences Provides Update on Vitaros NDA Following Receipt of FDA Feedback
Biopharmaceuticals Urology FDA
 HSMN NewsFeed - 13 Sep 2012
Apricus Biosciences' Wholly-Owned Subsidiary NexMed (U.S.A.) and Takeda Pharmaceuticals International GmbH Sign Exclusive License Agreement to Market Vitaros(R) in the United Kingdom
Biopharmaceuticals Licensing
 HSMN NewsFeed - 2 Jun 2011
Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jun 2010
Apnex Medical, Inc. Names Chas McKhann President, Chief Executive Officer
Devices Neurology Personnel
 HSMN NewsFeed - 3 Dec 2009
Apnex Medical, Inc. Raises Additional $14 Million
Devices Venture Capital
 HSMN NewsFeed - 3 Feb 2009
Warner Chilcott Announces Agreement to Acquire Topical Alprostadil Treatment for Erectile Dysfunction
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 20 Nov 2007
NexMed Confirms FDA Acceptance of NDA for Erectle Dysfunction Product
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 2 Nov 2007
NexMed Appoints Hem Pandya as Chief Operating Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 24 Sep 2007
NexMed Files NDA for Proprietary Erectile Dysfunction Treatment
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 20 Jun 2007
NexMed Appoints Vivian Liu as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jan 2007
NexMed Announces Patient Dosing in Phase 3 Program for Anti-Fungal Product
Biopharmaceuticals
 HSMN NewsFeed - 26 Jun 2006
NexMed Announces Termination of Alprox-TD Agreement With Schering AG and Provides Operational Update
Biopharmaceuticals Drug Delivery Licensing Distribution
Return to NewsFeed  

 Additional items found! 15

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 15 additional stories matching:
NexMed
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.